We are live on ! Find out more
ASP

Adams Street Partners Portfolio holdings

AUM $260M
1-Year Est. Return 30.38%
This Fund
S&P 500
This Quarter Est. Return
+33%
1 Year Est. Return
+30.38%
3 Year Est. Return
+351.96%
5 Year Est. Return
+202.05%
10 Year Est. Return
+1,159.77%
AUM
$153M
AUM Growth
+$11.2M
Cap. Flow
-$18.7M
Cap. Flow %
-12.23%
Top 10 Hldgs %
100%
Holding
7
New
1
Increased
Reduced
2
Closed
2

Top Buys

Rank Stock Value
1
PGY icon
Pagaya Technologies
PGY
+$11.5M

Top Sells

Rank Stock Value
1
IOT icon
Samsara
IOT
+$15.1M
2
PAY icon
Paymentus
PAY
+$7.02M
3
PVLA
Palvella Therapeutics
PVLA
+$6.74M
4
DASH icon
DoorDash
DASH
+$1.29M

Sector Composition

Rank Sector Weight
1 Technology 84.24%
2 Healthcare 15.76%
3 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RMNI icon
1
Rimini Street
RMNI
$432M
$110M 71.98%
23,565,433
CRVS icon
2
Corvus Pharmaceuticals
CRVS
$1.09B
$24.1M 15.76%
3,275,616
PGY icon
3
Pagaya Technologies
PGY
$1.41B
$10.5M 6.87%
+354,539
New +$11.5M
IOT icon
4
Samsara
IOT
$20.6B
$5.42M 3.54%
145,408
-407,677
-74% -$15.1M
PAY icon
5
Paymentus
PAY
$3.96B
$2.85M 1.86%
93,090
-212,478
-70% -$7.02M
DASH icon
6
DoorDash
DASH
$80.3B
-5,214
Closed -$1.29M
PVLA
7
Palvella Therapeutics
PVLA
$2.03B
-298,986
Closed -$6.74M

Similar funds

Adams Street Partners's Q3 2025 Portfolio in Review

As of Q3 2025, Adams Street Partners held 7 positions worth $153M, up 7.9% from $142M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Adams Street Partners withdrew a net $18.7M in Q3 2025, closing 2 positions and reducing 2 holdings. Its most notable exit was Palvella Therapeutics, an estimated $6.74M position sold in full.

By sector, the portfolio is most concentrated in Technology at 84% of assets, down from 85% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Adams Street Partners opened a new position in Pagaya Technologies worth $10.5M.

  • Adams Street Partners's largest Q3 2025 buy was Pagaya Technologies: 354,539 shares worth $10.5M.
  • Adams Street Partners's biggest Q3 2025 reduction was Samsara, cutting an estimated $15.1M.
  • Adams Street Partners fully exited Palvella Therapeutics in Q3 2025, selling an estimated $6.74M.
  • Adams Street Partners's ten largest holdings make up 100% of its $153M portfolio in Q3 2025.
  • Adams Street Partners opened 1 new position and closed 2 in Q3 2025.
  • Adams Street Partners's portfolio value rose 7.9% quarter-over-quarter to $153M.

Based on Adams Street Partners's 13F filing for Q3 2025, filed 14 Nov 2025.